Diagnosis of renal cancer by molecular urinalysis

Claus F. Eisenberger, Mark P. Schoenberg, Cheryl Enger, Steven Hortopan, Shefali Shah, Nan Haw Chow, Fray F. Marshall, David Sidransky

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Background: Organ-confined renal malignancies can be cured in the majority of patients, whereas more extensive lesions have a poor prognosis. We sought to develop a noninvasive test for renal cancer detection based on a novel molecular approach. Methods: Matched urine and serum DNA samples were obtained before surgery from 30 patients with clinically organ-confined solid renal masses (25 with malignant tumors and five with tumors of low malignant potential) and were subjected to microsatellite analysis. Serum samples and urine samples obtained from 16 individuals without clinical evidence of genitourinary malignancy served as controls. Results: Nineteen (76%) of the 25 patients with malignant tumors were found to have one or more microsatellite DNA alterations in their urine specimen, and 15 (60%) were found to have alterations in their serum DNA by microsatellite analysis. In every case, the microsatellite changes in urine or serum were identical to those found in the primary tumor. Three of five patients with tumors of low malignant potential were found to have DNA alterations in their urine, but none displayed alterations in their serum. Moreover, microsatellite alterations were not identified in either the urine or the serum samples from normal control subjects and patients with hematuria due to nephrolithiasis (renal stones). Conclusion: These data suggest that microsatellite DNA analysis of urine specimens provides a potentially valuable tool for the early detection of resectable kidney cancer. Furthermore, microsatellite analysis of serum samples reveals evidence of circulating tumor-specific DNA in approximately half of these patients and may reflect the propensity of these tumors to spread to distant sites at an early stage.

Original languageEnglish (US)
Pages (from-to)2028-2032
Number of pages5
JournalJournal of the National Cancer Institute
Volume91
Issue number23
StatePublished - Dec 1 1999
Externally publishedYes

Fingerprint

Urinalysis
Kidney Neoplasms
Microsatellite Repeats
Urine
Neoplasms
Serum
DNA
Kidney
Nephrolithiasis
Hematuria

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Eisenberger, C. F., Schoenberg, M. P., Enger, C., Hortopan, S., Shah, S., Chow, N. H., ... Sidransky, D. (1999). Diagnosis of renal cancer by molecular urinalysis. Journal of the National Cancer Institute, 91(23), 2028-2032.

Diagnosis of renal cancer by molecular urinalysis. / Eisenberger, Claus F.; Schoenberg, Mark P.; Enger, Cheryl; Hortopan, Steven; Shah, Shefali; Chow, Nan Haw; Marshall, Fray F.; Sidransky, David.

In: Journal of the National Cancer Institute, Vol. 91, No. 23, 01.12.1999, p. 2028-2032.

Research output: Contribution to journalArticle

Eisenberger, CF, Schoenberg, MP, Enger, C, Hortopan, S, Shah, S, Chow, NH, Marshall, FF & Sidransky, D 1999, 'Diagnosis of renal cancer by molecular urinalysis', Journal of the National Cancer Institute, vol. 91, no. 23, pp. 2028-2032.
Eisenberger CF, Schoenberg MP, Enger C, Hortopan S, Shah S, Chow NH et al. Diagnosis of renal cancer by molecular urinalysis. Journal of the National Cancer Institute. 1999 Dec 1;91(23):2028-2032.
Eisenberger, Claus F. ; Schoenberg, Mark P. ; Enger, Cheryl ; Hortopan, Steven ; Shah, Shefali ; Chow, Nan Haw ; Marshall, Fray F. ; Sidransky, David. / Diagnosis of renal cancer by molecular urinalysis. In: Journal of the National Cancer Institute. 1999 ; Vol. 91, No. 23. pp. 2028-2032.
@article{b85d2bc95c3a47abac0e7fa64499ca94,
title = "Diagnosis of renal cancer by molecular urinalysis",
abstract = "Background: Organ-confined renal malignancies can be cured in the majority of patients, whereas more extensive lesions have a poor prognosis. We sought to develop a noninvasive test for renal cancer detection based on a novel molecular approach. Methods: Matched urine and serum DNA samples were obtained before surgery from 30 patients with clinically organ-confined solid renal masses (25 with malignant tumors and five with tumors of low malignant potential) and were subjected to microsatellite analysis. Serum samples and urine samples obtained from 16 individuals without clinical evidence of genitourinary malignancy served as controls. Results: Nineteen (76{\%}) of the 25 patients with malignant tumors were found to have one or more microsatellite DNA alterations in their urine specimen, and 15 (60{\%}) were found to have alterations in their serum DNA by microsatellite analysis. In every case, the microsatellite changes in urine or serum were identical to those found in the primary tumor. Three of five patients with tumors of low malignant potential were found to have DNA alterations in their urine, but none displayed alterations in their serum. Moreover, microsatellite alterations were not identified in either the urine or the serum samples from normal control subjects and patients with hematuria due to nephrolithiasis (renal stones). Conclusion: These data suggest that microsatellite DNA analysis of urine specimens provides a potentially valuable tool for the early detection of resectable kidney cancer. Furthermore, microsatellite analysis of serum samples reveals evidence of circulating tumor-specific DNA in approximately half of these patients and may reflect the propensity of these tumors to spread to distant sites at an early stage.",
author = "Eisenberger, {Claus F.} and Schoenberg, {Mark P.} and Cheryl Enger and Steven Hortopan and Shefali Shah and Chow, {Nan Haw} and Marshall, {Fray F.} and David Sidransky",
year = "1999",
month = "12",
day = "1",
language = "English (US)",
volume = "91",
pages = "2028--2032",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "23",

}

TY - JOUR

T1 - Diagnosis of renal cancer by molecular urinalysis

AU - Eisenberger, Claus F.

AU - Schoenberg, Mark P.

AU - Enger, Cheryl

AU - Hortopan, Steven

AU - Shah, Shefali

AU - Chow, Nan Haw

AU - Marshall, Fray F.

AU - Sidransky, David

PY - 1999/12/1

Y1 - 1999/12/1

N2 - Background: Organ-confined renal malignancies can be cured in the majority of patients, whereas more extensive lesions have a poor prognosis. We sought to develop a noninvasive test for renal cancer detection based on a novel molecular approach. Methods: Matched urine and serum DNA samples were obtained before surgery from 30 patients with clinically organ-confined solid renal masses (25 with malignant tumors and five with tumors of low malignant potential) and were subjected to microsatellite analysis. Serum samples and urine samples obtained from 16 individuals without clinical evidence of genitourinary malignancy served as controls. Results: Nineteen (76%) of the 25 patients with malignant tumors were found to have one or more microsatellite DNA alterations in their urine specimen, and 15 (60%) were found to have alterations in their serum DNA by microsatellite analysis. In every case, the microsatellite changes in urine or serum were identical to those found in the primary tumor. Three of five patients with tumors of low malignant potential were found to have DNA alterations in their urine, but none displayed alterations in their serum. Moreover, microsatellite alterations were not identified in either the urine or the serum samples from normal control subjects and patients with hematuria due to nephrolithiasis (renal stones). Conclusion: These data suggest that microsatellite DNA analysis of urine specimens provides a potentially valuable tool for the early detection of resectable kidney cancer. Furthermore, microsatellite analysis of serum samples reveals evidence of circulating tumor-specific DNA in approximately half of these patients and may reflect the propensity of these tumors to spread to distant sites at an early stage.

AB - Background: Organ-confined renal malignancies can be cured in the majority of patients, whereas more extensive lesions have a poor prognosis. We sought to develop a noninvasive test for renal cancer detection based on a novel molecular approach. Methods: Matched urine and serum DNA samples were obtained before surgery from 30 patients with clinically organ-confined solid renal masses (25 with malignant tumors and five with tumors of low malignant potential) and were subjected to microsatellite analysis. Serum samples and urine samples obtained from 16 individuals without clinical evidence of genitourinary malignancy served as controls. Results: Nineteen (76%) of the 25 patients with malignant tumors were found to have one or more microsatellite DNA alterations in their urine specimen, and 15 (60%) were found to have alterations in their serum DNA by microsatellite analysis. In every case, the microsatellite changes in urine or serum were identical to those found in the primary tumor. Three of five patients with tumors of low malignant potential were found to have DNA alterations in their urine, but none displayed alterations in their serum. Moreover, microsatellite alterations were not identified in either the urine or the serum samples from normal control subjects and patients with hematuria due to nephrolithiasis (renal stones). Conclusion: These data suggest that microsatellite DNA analysis of urine specimens provides a potentially valuable tool for the early detection of resectable kidney cancer. Furthermore, microsatellite analysis of serum samples reveals evidence of circulating tumor-specific DNA in approximately half of these patients and may reflect the propensity of these tumors to spread to distant sites at an early stage.

UR - http://www.scopus.com/inward/record.url?scp=0033486035&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033486035&partnerID=8YFLogxK

M3 - Article

VL - 91

SP - 2028

EP - 2032

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 23

ER -